Clinical Trial Update: Japanese Phase 1 Multiple Ascending Dose Study [Phase 1]

View source ↗

Summary

Japanese Phase 1 multiple ascending dose study in Type 2 Diabetes Mellitus conducted by Bristol-Myers Squibb has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED